Shantan Reddy

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 829 citations · Full text

Cd19-targeted T Cells, Cancer Immunosurveillance, Immunology +8

Rapid manufacturing of non-activated potent CAR T cells

Saba Ghassemi, Joseph S. Durgin, Selene Nuñez-Cruz et al. · Nature Biomedical Engineering · 2022 · 255 citations · Full text

Cell Therapy, Medicine, T-regulatory Cell +6

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Mitesh J. Borad, Shantan Reddy, Nathan Bahary et al. · Journal of Clinical Oncology · 2014 · 186 citations · Full text

INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes

Eric A. Sherman, Christopher L. Nobles, Charles C. Berry et al. · Molecular Therapy — Methods & Clinical Development · 2016 · 127 citations · Full text

CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration

Christopher L. Nobles, Scott Sherrill-Mix, J.K. Everett et al. · Journal of Clinical Investigation · 2019 · 124 citations · Full text

Cell Therapy, Mixed-phenotype Acute Leukemia, T-regulatory Cell +19